http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102104551-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-9015 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y601-0101 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40 |
filingDate | 2018-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2020-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102104551-B1 |
titleOfInvention | Monoclonal antibodies specifically binding to MRS protein |
abstract | The present invention relates to an anti-MRS monoclonal antibody, and more specifically, specifically binds to fragments represented by amino acids 861 to 900 of the human-derived MRS (methionyl-tRNA synthetase) protein represented by SEQ ID NO: 1 It relates to an antibody or a fragment thereof, a method for producing the same, and a composition for diagnosing cancer comprising the same. The antibody or fragment thereof of the present invention specifically binds to human-derived MRS, and since there is no cross-reactivity with other proteins including the same ARS family, MRS can be detected, and thus can be usefully used to diagnose MRS-related cancer. . |
priorityDate | 2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1725.